How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP

BACKGROUND: Tenofovir/emtricitabine (TDF/FTC) used as pre-exposure prophylaxis (PrEP) has proven benefits in preventing HIV infection. Widespread use of TDF/FTC can only be justified if the preventative benefits outweigh potential risks of adverse events. A previous meta-analysis of TDF/FTC compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilkington, Victoria, Hill, Andrew, Hughes, Sophie, Nwokolo, Nneka, Pozniak, Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mediscript Ltd 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248833/
https://www.ncbi.nlm.nih.gov/pubmed/30515300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248833/
https://www.ncbi.nlm.nih.gov/pubmed/30515300

Ejemplares similares